• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非 B 非 C 型肝细胞癌的治疗结果与丙型肝炎病毒清除患者相关。

Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus Eradication.

机构信息

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

出版信息

J Gastrointest Surg. 2020 Aug;24(8):1809-1817. doi: 10.1007/s11605-019-04339-1. Epub 2019 Aug 5.

DOI:10.1007/s11605-019-04339-1
PMID:31385170
Abstract

PURPOSE

This study aimed to evaluate survival outcomes in patients with non-B non-C hepatocellular carcinoma (NBNC-HCC) with reference to patients with HCC achieving sustained virological response (SVR) by preoperative interferon (IFN) treatment for chronic hepatitis C.

METHODS

We examined 781 patients who underwent hepatic resection for HCC. They were classified into NBNC-HCC, SVR-HCC, and non-SVR HCC groups.

RESULTS

Multivariate analysis for recurrence-free survival (RFS) and overall survival (OS) revealed that the adjusted hazard ratios (HR) of NBNC-HCC and non-SVR HCC groups with reference to the SVR-HCC group were 1.46 (p = 0.10) and 2.10 (p < 0.001), respectively, for RFS, and 1.69 (p = 0.024) and 2.11 (p < 0.001), respectively, for OS. Worsening of Child-Pugh grade at recurrence was confirmed in 21 patients (17.1%) with NBNC-HCC but not in those with SVR-HCC (p = 0.017, SVR vs. NBNC). In the NBNC-HCC group, hepatic resection for intrahepatic recurrence was adopted in 17.4% of patients without worsening of Child-Pugh grade at recurrence, whereas hepatic resection was not adopted in those with grade worsening. Among patients with alcoholic hepatitis, Child-Pugh grade worsening at recurrence was more frequently observed in patients with sobriety than those without sobriety (14.3% vs. 46.2%, p = 0.049).

CONCLUSIONS

NBNC-HCC patients had an increased risk for overall death as compared with those with SVR-HCC. Worsening of background liver function may reduce the chances of re-hepatic resection for recurrence and increase the risk for overall death in NBNC-HCC patients. For alcoholic hepatitis patients, sobriety may prevent deterioration of liver function after surgery.

摘要

目的

本研究旨在评估术前接受干扰素(IFN)治疗慢性丙型肝炎实现持续病毒学应答(SVR)的患者与非乙型非丙型肝细胞癌(NBNC-HCC)患者的生存结局。

方法

我们检查了 781 例接受 HCC 肝切除术的患者。他们被分为 NBNC-HCC、SVR-HCC 和非 SVR HCC 组。

结果

多变量分析复发无进展生存(RFS)和总生存(OS)显示,与 SVR-HCC 组相比,NBNC-HCC 和非 SVR HCC 组的调整后的风险比(HR)分别为 1.46(p=0.10)和 2.10(p<0.001),用于 RFS,分别为 1.69(p=0.024)和 2.11(p<0.001),用于 OS。在 NBNC-HCC 组中,21 例(17.1%)患者在复发时出现 Child-Pugh 分级恶化,但在 SVR-HCC 组中未出现(p=0.017,SVR 与 NBNC)。在 NBNC-HCC 组中,在没有复发时 Child-Pugh 分级恶化的患者中,17.4%的患者接受了肝内复发的肝切除术,而在分级恶化的患者中则没有接受肝切除术。在酒精性肝炎患者中,在复发时出现肝功能恶化的患者中,戒酒的患者比不戒酒的患者更常见(14.3%比 46.2%,p=0.049)。

结论

与 SVR-HCC 患者相比,NBNC-HCC 患者的总体死亡风险增加。背景肝功能恶化可能会降低 NBNC-HCC 患者再次肝切除治疗复发的机会,并增加其总体死亡风险。对于酒精性肝炎患者,戒酒可能会防止手术后肝功能恶化。

相似文献

1
Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus Eradication.非 B 非 C 型肝细胞癌的治疗结果与丙型肝炎病毒清除患者相关。
J Gastrointest Surg. 2020 Aug;24(8):1809-1817. doi: 10.1007/s11605-019-04339-1. Epub 2019 Aug 5.
2
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.比较 HBV 阳性、HCV 阳性和非 B 非 C 型肝细胞癌患者的手术治疗效果:一项全国性的 11950 例患者研究。
Ann Surg. 2015 Mar;261(3):513-20. doi: 10.1097/SLA.0000000000000821.
3
Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.非B非C型肝细胞癌患者的术后结局:对有乙型肝炎感染史患者的亚组分析
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1034-40. doi: 10.1245/s10434-015-4845-0. Epub 2015 Sep 8.
4
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy.丙型肝炎病毒相关肝细胞癌的手术治疗结果:特别提及干扰素治疗的持续病毒学应答
Am Surg. 2017 Nov 1;83(11):1246-1255.
5
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.慢性丙型肝炎病毒相关代偿性肝硬化患者获得持续病毒学应答后,其肝细胞癌患者的生存率得到提高。
Liver Int. 2017 Oct;37(10):1526-1534. doi: 10.1111/liv.13452. Epub 2017 May 20.
6
Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response -An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response.干扰素对丙型肝炎病毒相关肝细胞癌患者持续病毒学应答预后的影响——术前与术后持续病毒学应答的额外比较
Kurume Med J. 2023 Apr 4;68(1):9-18. doi: 10.2739/kurumemedj.MS681001. Epub 2023 Feb 8.
7
Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.乙型肝炎病毒表面抗原阴性和丙型肝炎病毒抗体阴性肝细胞癌:切除术后早期和晚期肝内复发的临床特征、结局和危险因素。
Cancer. 2013 Jan 1;119(1):126-35. doi: 10.1002/cncr.27697. Epub 2012 Jun 26.
8
Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.在接受包括干扰素在内的抗病毒治疗后获得持续病毒学应答的慢性丙型肝炎患者,在接受肝细胞癌肝切除术前的良好预后。
Anticancer Res. 2015 Dec;35(12):6963-9.
9
Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma.干扰素治疗持续病毒学应答对丙型肝炎病毒相关肝细胞癌复发的影响。
Ann Surg Oncol. 2017 Oct;24(11):3196-3202. doi: 10.1245/s10434-017-6008-y. Epub 2017 Jul 13.
10
Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.与乙型或丙型肝炎病毒感染患者相比,影响非B非C型肝细胞癌患者初次肝切除术后生存和复发的临床病理因素
Biomed Res Int. 2014;2014:975380. doi: 10.1155/2014/975380. Epub 2014 Mar 13.

引用本文的文献

1
Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study.肝细胞癌分期系统的比较预后性能:来自越南队列研究的证据。
World J Hepatol. 2025 May 27;17(5):104041. doi: 10.4254/wjh.v17.i5.104041.
2
Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study.目的:经动脉术前栓塞治疗大肝癌:一项回顾性队列研究。
World J Surg Oncol. 2022 Mar 22;20(1):90. doi: 10.1186/s12957-022-02563-9.
3
Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease.

本文引用的文献

1
Prognostic Factors and Staging Systems in Hepatocellular Carcinoma.肝细胞癌的预后因素与分期系统
Exp Clin Transplant. 2017 Mar;15(Suppl 2):45-49. doi: 10.6002/ect.TOND16.L11.
2
Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.非B非C型肝细胞癌肝切除术后的特征及预后
Hepatogastroenterology. 2012 Sep;59(118):1889-92. doi: 10.5754/hge10778.
戒酒对酒精性肝病患者肝细胞癌肝切除术后生存的影响。
Ann Med Surg (Lond). 2021 Jul 29;68:102644. doi: 10.1016/j.amsu.2021.102644. eCollection 2021 Aug.